47 related articles for article (PubMed ID: 34859284)
1. A novel mouse model for the identification of thioredoxin-1 protein interactions.
Booze ML; Hansen JM; Vitiello PF
Free Radic Biol Med; 2016 Oct; 99():533-543. PubMed ID: 27639450
[TBL] [Abstract][Full Text] [Related]
2. NAA10 gene expression is associated with mesenchymal transition, dedifferentiation, and progression of clear cell renal cell carcinoma.
Duong NX; Nguyen T; Le MK; Sawada N; Kira S; Kondo T; Inukai T; Mitsui T
Pathol Res Pract; 2024 Mar; 255():155191. PubMed ID: 38340582
[TBL] [Abstract][Full Text] [Related]
3. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.
Cotta BH; Choueiri TK; Cieslik M; Ghatalia P; Mehra R; Morgan TM; Palapattu GS; Shuch B; Vaishampayan U; Van Allen E; Ari Hakimi A; Salami SS
Eur Urol; 2023 Aug; 84(2):166-175. PubMed ID: 37085424
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Zhou C; Deng H; Fang Y; Wei Z; Shen Y; Qiu S; Ye D; Shen Z; Shen Y
Heliyon; 2023 Nov; 9(11):e21381. PubMed ID: 37954266
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress-related gene model predicts prognosis and guides therapies in lung adenocarcinoma.
Song Y; Ma J; Fang L; Tang M; Gao X; Zhu D; Liu W
BMC Bioinformatics; 2023 Jun; 24(1):255. PubMed ID: 37328788
[TBL] [Abstract][Full Text] [Related]
6. The Importance of Thioredoxin-1 in Health and Disease.
Oberacker T; Kraft L; Schanz M; Latus J; Schricker S
Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237944
[TBL] [Abstract][Full Text] [Related]
7. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin promotes survival signaling events under nitrosative/oxidative stress associated with cancer development.
Monteiro HP; Ogata FT; Stern A
Biomed J; 2017 Aug; 40(4):189-199. PubMed ID: 28918907
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
Ribback S; Winter S; Klatte T; Schaeffeler E; Gellert M; Stühler V; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
World J Urol; 2022 Mar; 40(3):739-746. PubMed ID: 34859284
[TBL] [Abstract][Full Text] [Related]
10. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
11. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
12.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression.
Shan W; Zhong W; Zhao R; Oberley TD
Free Radic Biol Med; 2010 Dec; 49(12):2078-87. PubMed ID: 20955789
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
